Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2022

August 2017 | 97 pages | ID: G568FB78C83EN
QYResearch

Abstracts

This report studies the global Companion Diagnostic Tests in Oncology market, analyzes and researches the Companion Diagnostic Tests in Oncology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• F. Hoffman LA Roche Ltd.
• QIAGEN, Illumina, Inc.
• Abbott
• Agilent Technologies, Inc.
• Genomic Health, Inc.
• bioMerieux SA
• BioGenex
• AGENDIA NV
• Siemens Healthcare GmBH
• Thermo Fisher Scientific, Inc.

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Companion Diagnostic Tests in Oncology can be split into

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Liver Cancer
• Melanoma
• Others

Market segment by Application, Companion Diagnostic Tests in Oncology can be split into

• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Research Institutes
• Others

Contents

Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF COMPANION DIAGNOSTIC TESTS IN ONCOLOGY

1.1 Companion Diagnostic Tests in Oncology Market Overview
  1.1.1 Companion Diagnostic Tests in Oncology Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Companion Diagnostic Tests in Oncology Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Companion Diagnostic Tests in Oncology Market by Type
  1.3.1 Breast Cancer
  1.3.2 Lung Cancer
  1.3.3 Colorectal Cancer
  1.3.4 Liver Cancer
  1.3.5 Melanoma
  1.3.6 Others
1.4 Companion Diagnostic Tests in Oncology Market by End Users/Application
  1.4.1 Pharmaceutical & Biotechnology Companies
  1.4.2 Medical Device Companies
  1.4.3 Research Institutes
  1.4.4 Others

2 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY COMPETITION ANALYSIS BY PLAYERS

2.1 Companion Diagnostic Tests in Oncology Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 F. Hoffman LA Roche Ltd.
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 QIAGEN, Illumina, Inc.
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Abbott
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Agilent Technologies, Inc.
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Genomic Health, Inc.
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 bioMerieux SA
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 BioGenex
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 AGENDIA NV
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Siemens Healthcare GmBH
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Thermo Fisher Scientific, Inc.
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Companion Diagnostic Tests in Oncology Revenue (Value) (2012-2017)
  3.10.5 Recent Developments

4 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Companion Diagnostic Tests in Oncology Market Size by Type (2012-2017)
4.2 Global Companion Diagnostic Tests in Oncology Market Size by Application (2012-2017)
4.3 Potential Application of Companion Diagnostic Tests in Oncology in Future
4.4 Top Consumer/End Users of Companion Diagnostic Tests in Oncology

5 UNITED STATES COMPANION DIAGNOSTIC TESTS IN ONCOLOGY DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Companion Diagnostic Tests in Oncology Market Size (2012-2017)
5.2 United States Companion Diagnostic Tests in Oncology Market Size and Market Share by Players (2016 and 2017)

6 EU COMPANION DIAGNOSTIC TESTS IN ONCOLOGY DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Companion Diagnostic Tests in Oncology Market Size (2012-2017)
6.2 EU Companion Diagnostic Tests in Oncology Market Size and Market Share by Players (2016 and 2017)

7 JAPAN COMPANION DIAGNOSTIC TESTS IN ONCOLOGY DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Companion Diagnostic Tests in Oncology Market Size (2012-2017)
7.2 Japan Companion Diagnostic Tests in Oncology Market Size and Market Share by Players (2016 and 2017)

8 CHINA COMPANION DIAGNOSTIC TESTS IN ONCOLOGY DEVELOPMENT STATUS AND OUTLOOK

8.1 China Companion Diagnostic Tests in Oncology Market Size (2012-2017)
8.2 China Companion Diagnostic Tests in Oncology Market Size and Market Share by Players (2016 and 2017)

9 INDIA COMPANION DIAGNOSTIC TESTS IN ONCOLOGY DEVELOPMENT STATUS AND OUTLOOK

9.1 India Companion Diagnostic Tests in Oncology Market Size (2012-2017)
9.2 India Companion Diagnostic Tests in Oncology Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA COMPANION DIAGNOSTIC TESTS IN ONCOLOGY DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2012-2017)
10.2 Southeast Asia Companion Diagnostic Tests in Oncology Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Companion Diagnostic Tests in Oncology Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
  11.1.2 EU Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
  11.1.4 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
  11.1.5 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2017-2022)
11.2 Global Companion Diagnostic Tests in Oncology Market Size (Value) by Type (2017-2022)
11.3 Global Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022)

12 COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET DYNAMICS

12.1 Companion Diagnostic Tests in Oncology Market Opportunities
12.2 Companion Diagnostic Tests in Oncology Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Companion Diagnostic Tests in Oncology Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Companion Diagnostic Tests in Oncology Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Companion Diagnostic Tests in Oncology Product Scope
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) (2012-2017)
Table Global Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Companion Diagnostic Tests in Oncology Market Share by Regions in 2016
Figure United States Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Companion Diagnostic Tests in Oncology Market Share by Type in 2016
Figure Breast Cancer Market Size (Million USD) and Growth Rate (2012-2017)
Figure Lung Cancer Market Size (Million USD) and Growth Rate (2012-2017)
Figure Colorectal Cancer Market Size (Million USD) and Growth Rate (2012-2017)
Figure Liver Cancer Market Size (Million USD) and Growth Rate (2012-2017)
Figure Melanoma Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Companion Diagnostic Tests in Oncology Market Share by Application in 2016
Figure Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate in Pharmaceutical & Biotechnology Companies (2012-2017)
Figure Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate in Medical Device Companies (2012-2017)
Figure Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate in Research Institutes (2012-2017)
Figure Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Companion Diagnostic Tests in Oncology Market Size (Million USD) by Players (2016 and 2017)
Figure Companion Diagnostic Tests in Oncology Market Size Share by Players in 2016
Figure Companion Diagnostic Tests in Oncology Market Size Share by Players in 2017
Table F. Hoffman LA Roche Ltd. Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of F. Hoffman LA Roche Ltd. (2012-2017)
Figure F. Hoffman LA Roche Ltd. Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table QIAGEN, Illumina, Inc. Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of QIAGEN, Illumina, Inc. (2012-2017)
Figure QIAGEN, Illumina, Inc. Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table Abbott Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of Abbott (2012-2017)
Figure Abbott Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table Agilent Technologies, Inc. Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of Agilent Technologies, Inc. (2012-2017)
Figure Agilent Technologies, Inc. Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table Genomic Health, Inc. Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of Genomic Health, Inc. (2012-2017)
Figure Genomic Health, Inc. Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table bioMerieux SA Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of bioMerieux SA (2012-2017)
Figure bioMerieux SA Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table BioGenex Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of BioGenex (2012-2017)
Figure BioGenex Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table AGENDIA NV Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of AGENDIA NV (2012-2017)
Figure AGENDIA NV Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table Siemens Healthcare GmBH Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of Siemens Healthcare GmBH (2012-2017)
Figure Siemens Healthcare GmBH Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table Thermo Fisher Scientific, Inc. Basic Information List
Table Companion Diagnostic Tests in Oncology Business Revenue (Million USD) of Thermo Fisher Scientific, Inc. (2012-2017)
Figure Thermo Fisher Scientific, Inc. Companion Diagnostic Tests in Oncology Business Revenue Market Share in 2016
Table Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Type (2012-2017)
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2012
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2013
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2014
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2015
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2016
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2017
Table Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application (2012-2017)
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2012
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2013
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2014
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2015
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2016
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Companion Diagnostic Tests in Oncology
Figure United States Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Companion Diagnostic Tests in Oncology Market Size (Million USD) by Players (2012-2017)
Figure United States Companion Diagnostic Tests in Oncology Market Size Share by Players in 2016
Figure United States Companion Diagnostic Tests in Oncology Market Size Share by Players in 2017
Figure EU Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Companion Diagnostic Tests in Oncology Market Size (Million USD) by Players (2012-2017)
Figure EU Companion Diagnostic Tests in Oncology Market Size Share by Players in 2016
Figure EU Companion Diagnostic Tests in Oncology Market Size Share by Players in 2017
Figure Japan Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Companion Diagnostic Tests in Oncology Market Size (Million USD) by Players (2012-2017)
Figure Japan Companion Diagnostic Tests in Oncology Market Size Share by Players in 2016
Figure Japan Companion Diagnostic Tests in Oncology Market Size Share by Players in 2017
Figure China Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Companion Diagnostic Tests in Oncology Market Size (Million USD) by Players (2012-2017)
Figure China Companion Diagnostic Tests in Oncology Market Size Share by Players in 2016
Figure China Companion Diagnostic Tests in Oncology Market Size Share by Players in 2017
Figure India Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Companion Diagnostic Tests in Oncology Market Size (Million USD) by Players (2012-2017)
Figure India Companion Diagnostic Tests in Oncology Market Size Share by Players in 2016
Figure India Companion Diagnostic Tests in Oncology Market Size Share by Players in 2017
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size Share by Players in 2016
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size Share by Players in 2017
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Regions (2017-2022)
Table Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Regions (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions in 2017
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions in 2022
Figure United States Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Type (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2017
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Type in 2022
Table Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application (2017-2022)
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2017
Figure Global Companion Diagnostic Tests in Oncology Market Size (Million USD) by Application in 2022